PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35567995-0	2022	ACSL4 promotes colorectal cancer and is a potential therapeutic target of emodin.	Emodin	74-80	acyl-CoA synthetase long chain family member 4	Homo sapiens	0-5	
35567995-9	2022	A docking simulation assay and an MST assay were performed to explore the potential mode of emodin binding to ACSL4.	Emodin	92-98	acyl-CoA synthetase long chain family member 4	Homo sapiens	110-115	
35567995-14	2022	Docking simulation and MST assay confirmed that emodin can directly bind to ACSL4 target.	Emodin	48-54	acyl-CoA synthetase long chain family member 4	Homo sapiens	76-81	
35567995-15	2022	Moreover, ACSL4 overexpression abolished the inhibitory effect of emodin on VEGF secretion and VEGFR1 and VEGFR2 expression, but VEGFR1 and VEGFR2 overexpression did not affect the inhibitory effect of emodin on ACSL4 expression and VEGF secretion.	Emodin	66-72	acyl-CoA synthetase long chain family member 4	Homo sapiens	10-15	
35567995-15	2022	Moreover, ACSL4 overexpression abolished the inhibitory effect of emodin on VEGF secretion and VEGFR1 and VEGFR2 expression, but VEGFR1 and VEGFR2 overexpression did not affect the inhibitory effect of emodin on ACSL4 expression and VEGF secretion.	Emodin	66-72	acyl-CoA synthetase long chain family member 4	Homo sapiens	212-217	
35567995-15	2022	Moreover, ACSL4 overexpression abolished the inhibitory effect of emodin on VEGF secretion and VEGFR1 and VEGFR2 expression, but VEGFR1 and VEGFR2 overexpression did not affect the inhibitory effect of emodin on ACSL4 expression and VEGF secretion.	Emodin	202-208	acyl-CoA synthetase long chain family member 4	Homo sapiens	10-15